odiparcil has been researched along with Mucopolysaccharidoses in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abitbol, JL; Chowdary, P; Faudot-Vernier, E; Fiquet, A; Guffon, N; Hendriksz, CJ; Hennermann, JB; Hughes, D; Huot-Marchand, P; Lacombe, O; Richard, MP; Tallandier, M; Teles, EL | 1 |
1 trial(s) available for odiparcil and Mucopolysaccharidoses
| Article | Year |
|---|---|
Oral treatment for mucopolysaccharidosis VI: Outcomes of the first phase IIa study with odiparcil.
Topics: Enzyme Replacement Therapy; Glycosaminoglycans; Glycosides; Humans; Mucopolysaccharidoses; Mucopolysaccharidosis VI; N-Acetylgalactosamine-4-Sulfatase | 2022 |